// insider-profile

KREHER NERISSA

DirectorTitleChief Medical OfficerView on SEC.gov ↗

This page tracks every SEC Form 4 filing by KREHER NERISSA, Chief Medical Officer: 28 transactions in total, including 1 open-market purchase and 7 sales. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.

// activity-summary

No insider transactions in the last 30 days.

// track-record

$10K
Total purchased
$0
Total sold
1
1B · 0S transactions
Net buyer
Overall direction

Most active in

Largest trade: $10K in RZLT (Jun 2025)Filing history: Mar 2023Jul 2026Based on last 28 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 1, 2026KREHER NERISSAXERS
Award
37,910$8.00$303K
Jul 1, 2026KREHER NERISSAXERS
Award
33,582$0.00$0K
Nov 19, 2025KREHER NERISSARZLT
Award
21,000$0.00$0K
Nov 19, 2025KREHER NERISSARZLT
Award
12,000$0.00$0K
Jun 13, 2025KREHER NERISSARZLT
Purchase
3,076$3.25$10K

23 more transactions hidden

Free account · No credit card required

Building something? Get API access →

// how to read this

Reading an insider's Form 4 history

Corporate insiders — directors, officers, and holders of more than 10% of a company's stock — must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.

The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.